Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting

Maybe this is part of the problem.

The patent dispute closed with a finding that HTC had infringed six claims in a microprocessing patent co-owned by TPL.

TPL had filed for bankruptcy earlier in the year.

The news comes as HTC announced its first ever quarterly loss of $3.5 billion Taiwan dollars, or around £738 million.

"This represents an extraordinary victory and vindication for the '336 patent and sends a strong signal to the marketplace that infringers of the MMP portfolio will be held accountable for their actions," said Cliff Flowers, TPL’s Interim Chief Executive Officer.
Read more at http://www.thedrum.com/news/2013/10/04/htc-loses-1-million-patent-case-and-posts-quarterly-loss#Upbt57hezFXpig0R.99

Stuff like this should be corrected, can't you see potential investors reading this, then try to locate and buy TPL stock?

Share
New Message
Please login to post a reply